Search research articles
Contact Us
Filters
Showing results (121-130 of 316) with videos related to
Page
of 32
Sort By:
Applied Health Economics and Health Policy
|
August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Josh J Carlson, Katie Gries, Kai Yeung, et al.
Journal of Medical Economics
|
August 14, 2012
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
Roman Casciano, Maruit Chulikavit, Allison Perrin, et al.
Health Economics
|
June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanoma
Meng Li, Anirban Basu, Caroline S Bennette, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Value in Health Regional Issues
|
February 22, 2023
Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses
Bruce Wang, Elizabeth Wu, Dirk Rassloff, et al.
Applied Health Economics and Health Policy
|
February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Bethany Shinkins, A Joy Allen, James Karichu, et al.
Journal of Medical Economics
|
July 12, 2011
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
Sean D Sullivan, Louis P Garrison, Harald Rinde, et al.
Frontiers in Pharmacology
|
April 25, 2022
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
András Incze, Zoltán Kaló, Jaime Espín, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
December 27, 2016
Cost-effectiveness analysis of the orbital atherectomy system: Two-year follow-up
Louis P Garrison, Marita R Zimmermann, Christopher H Young, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Page
of 32
Search research articles
Search
Showing results (121-130 of 316) with videos related to
Sort By:
Page
of 32
Applied Health Economics and Health Policy
|
August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Josh J Carlson, Katie Gries, Kai Yeung, et al.
Journal of Medical Economics
|
August 14, 2012
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
Roman Casciano, Maruit Chulikavit, Allison Perrin, et al.
Health Economics
|
June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanoma
Meng Li, Anirban Basu, Caroline S Bennette, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Value in Health Regional Issues
|
February 22, 2023
Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses
Bruce Wang, Elizabeth Wu, Dirk Rassloff, et al.
Applied Health Economics and Health Policy
|
February 5, 2024
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Bethany Shinkins, A Joy Allen, James Karichu, et al.
Journal of Medical Economics
|
July 12, 2011
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
Sean D Sullivan, Louis P Garrison, Harald Rinde, et al.
Frontiers in Pharmacology
|
April 25, 2022
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
András Incze, Zoltán Kaló, Jaime Espín, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
December 27, 2016
Cost-effectiveness analysis of the orbital atherectomy system: Two-year follow-up
Louis P Garrison, Marita R Zimmermann, Christopher H Young, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Page
of 32